Ethyl Ferulate

Ethyl Ferulate

SCHEMBL187331

CCOC(=O)/C=C/c1ccc(O)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 1.00
TTR P02766 2/20 0.74
DPP4 P27487 1/20 0.74
EPHX2 P34913 1/20 0.74
FDPS P14324 1/20 0.71
MET P08581 8/20 0.70
CA12 O43570 4/20 0.70
CA4 P22748 4/20 0.70
CA6 P23280 4/20 0.70
CA5A P35218 4/20 0.70
CA7 P43166 4/20 0.70
CA9 Q16790 4/20 0.70
CA14 Q9ULX7 4/20 0.70
CA5B Q9Y2D0 4/20 0.70
CYP2D6 P10635 3/20 0.69
CYP2C9 P11712 2/20 0.69
TSHR P16473 2/20 0.69
HSD17B10 Q99714 2/20 0.69
CYP1A2 P05177 2/20 0.69
ALOX5 P09917 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Ferulate SCHEMBL73132 1.00 MAOB (1.00) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL29392788 1.00 MAOB (1.00) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL31491261 1.00 MAOB (1.00) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL21807752 1.00 MAOB (1.00) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL17866311 1.00 MAOB (1.00) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL29009254 0.94 MAOB (0.88) MAOBTTRDPP4EPHX2FDPS
SCHEMBL16888007 0.92 MAOB (0.85) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL21801021 0.91 MAOB (0.83) MAOBTTRDPP4EPHX2FDPS
Ethyl Ferulate SCHEMBL21801022 0.91 MAOB (0.83) MAOBTTRDPP4EPHX2FDPS
Ethyl Caffeate SCHEMBL21801020 0.91 MAOB (0.83) MAOBTTRDPP4EPHX2FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4510995-B1 COSMETIC COMPOSITION CONTAINING A VESICULAR CONCENTRATE CONSISTING OF A WATER SOLUTION OF LIPID VESICLES FOR COSMETIC PRODUCTS, COSMETIC PRODUCTS CONTAINING SAID COSMETIC COMPOSITION AND METHOD FOR THEIR PRODUCTION INTERCOS ITALIANA (IT) 2026-04-15 EP claimed
EP-4431532-A2 REACTIVE SURFACTANTS Stepan Company (US) 2024-09-18 EP claimed
EP-4326892-A1 METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA NAOS Institute of Life Science (FR) 2024-02-28 EP claimed
EP-3807086-B1 AN ELECTROSTATICALLY LAMINATED NANOFIBRE COSMETIC COVER WITH A REMOVABLE LAMINATION LAYER, METHOD FOR ITS LAMINATION AND USE NANOPHARMA A S (CZ) 2023-10-11 EP claimed
WO-2022223928-A1 METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA NAOS INSTITUTE OF LIFE SCIENCE (FR) 2022-10-27 WO claimed
US-20220177403-A1 REACTIVE SURFACTANTS STEPAN COMPANY 2022-06-09 US claimed
CN-106998684-B Compositions comprising ferulic acid ethyl ester and aryl alkanol 奇科迈尔有限公司 2022-02-25 CN claimed
US-20190311703-A1 ACOUSTIC TRAUMA SYSTEM FOR LARVAL FISH WASHINGTON STATE UNIVERSITY 2019-10-10 US claimed
CN-106565469-A Efficient herbicidal activity of ethyl 4-hydroxy-3-methoxycinnamate 张利辉 2017-04-19 CN claimed
CN-106191142-A A kind of preparation method of the biodiesel rich in phenolic acid structure ester 中国农业科学院油料作物研究所 2016-12-07 CN claimed
CN-106046950-A Preparation method of biological nano coating based on half-bred micelles 江南大学 2016-10-26 CN claimed
CN-106038342-A Novel sunscreen anti-oxidation skin-whitening cosmetic composition and preparation method thereof 陕西畅想制药有限公司 2016-10-26 CN claimed
CN-101934093-A Medicament coating material and preparation method INST METAL RES CHINESE ACAD SC 2011-01-05 CN claimed
CN-101919855-A Pharmacy application of piperazine ferulate SICHUAN BAOSHENGKANG PHARMACEUTICAL CO LTD 2010-12-22 CN claimed
CN-1857622-A Medicine composition and preparation containing effective components of gastrodia tuber and Chuanxiong rhizome OU SU (CN) 2006-11-08 CN claimed
CN-1555834-A Medicinal composition containing salvia root effective component and ligusticum effecive component and its preparation 广州安健实业发展有限公司 2004-12-22 CN claimed
US-20010056211-A1 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity NATIONAL SCIENCE COUNCIL (TW) 2001-12-27 US claimed
CN-1100631-A Chondroprotective agents KUREHA CHEMICAL IND CO LTD (JP) 1995-03-29 CN claimed
EP-4732823-A1 COSMETIC PREPARATION Laverana GmbH & Co. KG (DE) 2026-04-29 EP disclosed
CN-1100631-A Chondroprotective agents KUREHA CHEMICAL IND CO LTD (JP) 1995-03-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177403-A1 REACTIVE SURFACTANTS SMURF1, STS, ESD MAOB 3056/4885TTR 2235/4885DPP4 4798/4885
US-20010056211-A1 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity ADRB1, ADRA1A, ADRA1B MAOB 227/4885TTR 2097/4885DPP4 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.